Tedder T - Search Results

1

A glycoengineered anti-CD19 antibody with potent antibody-dependent cellular cytotoxicity activity in vitro and lymphoma growth inhibition in vivo.

Ward E, Mittereder N, Kuta E, Sims GP, Bowen MA, Dall'Acqua W, Tedder T, Kiener P, Coyle AJ, Wu H, Jallal B, Herbst R. Ward E, et al. Among authors: tedder t. Br J Haematol. 2011 Nov;155(4):426-37. doi: 10.1111/j.1365-2141.2011.08857.x. Epub 2011 Sep 9. Br J Haematol. 2011. PMID: 21902688 Free article.

2

B-cell depletion in vitro and in vivo with an afucosylated anti-CD19 antibody.

Herbst R, Wang Y, Gallagher S, Mittereder N, Kuta E, Damschroder M, Woods R, Rowe DC, Cheng L, Cook K, Evans K, Sims GP, Pfarr DS, Bowen MA, Dall'Acqua W, Shlomchik M, Tedder TF, Kiener P, Jallal B, Wu H, Coyle AJ. Herbst R, et al. J Pharmacol Exp Ther. 2010 Oct;335(1):213-22. doi: 10.1124/jpet.110.168062. Epub 2010 Jul 6. J Pharmacol Exp Ther. 2010. PMID: 20605905

3

Germinal center B cell depletion diminishes CD4+ follicular T helper cells in autoimmune mice.

Yusuf I, Stern J, McCaughtry TM, Gallagher S, Sun H, Gao C, Tedder T, Carlesso G, Carter L, Herbst R, Wang Y. Yusuf I, et al. Among authors: tedder t. PLoS One. 2014 Aug 7;9(8):e102791. doi: 10.1371/journal.pone.0102791. eCollection 2014. PLoS One. 2014. PMID: 25101629 Free PMC article.

4

The Tumor Microenvironment Regulates CD19 and CD20 Immunotherapy for Lymphoma.

Lykken JM, Tedder TF. Lykken JM, et al. Cancer J. 2015 Jul-Aug;21(4):351-6. doi: 10.1097/PPO.0000000000000137. Cancer J. 2015. PMID: 26222089 Review.

5

CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies.

Kohrt HE, Houot R, Goldstein MJ, Weiskopf K, Alizadeh AA, Brody J, Müller A, Pachynski R, Czerwinski D, Coutre S, Chao MP, Chen L, Tedder TF, Levy R. Kohrt HE, et al. Blood. 2011 Feb 24;117(8):2423-32. doi: 10.1182/blood-2010-08-301945. Epub 2010 Dec 30. Blood. 2011. PMID: 21193697 Free PMC article. Retracted.

6

Fcgamma receptor-dependent effector mechanisms regulate CD19 and CD20 antibody immunotherapies for B lymphocyte malignancies and autoimmunity.

Tedder TF, Baras A, Xiu Y. Tedder TF, et al. Springer Semin Immunopathol. 2006 Dec;28(4):351-64. doi: 10.1007/s00281-006-0057-9. Epub 2006 Nov 8. Springer Semin Immunopathol. 2006. PMID: 17091246

7

Immunotherapy using unconjugated CD19 monoclonal antibodies in animal models for B lymphocyte malignancies and autoimmune disease.

Yazawa N, Hamaguchi Y, Poe JC, Tedder TF. Yazawa N, et al. Proc Natl Acad Sci U S A. 2005 Oct 18;102(42):15178-83. doi: 10.1073/pnas.0505539102. Epub 2005 Oct 10. Proc Natl Acad Sci U S A. 2005. PMID: 16217038 Free PMC article.

8

CD19: a promising B cell target for rheumatoid arthritis.

Tedder TF. Tedder TF. Nat Rev Rheumatol. 2009 Oct;5(10):572-7. doi: 10.1038/nrrheum.2009.184. Nat Rev Rheumatol. 2009. PMID: 19798033 Review.

9

Anti-CD22 ligand-blocking antibody HB22.7 has independent lymphomacidal properties and augments the efficacy of 90Y-DOTA-peptide-Lym-1 in lymphoma xenografts.

Tuscano JM, O'Donnell RT, Miers LA, Kroger LA, Kukis DL, Lamborn KR, Tedder TF, DeNardo GL. Tuscano JM, et al. Among authors: tedder tf. Blood. 2003 May 1;101(9):3641-7. doi: 10.1182/blood-2002-08-2629. Epub 2003 Jan 2. Blood. 2003. PMID: 12511412 Free article.

10

A reevaluation of CD22 expression in human lung cancer.

Pop LM, Barman S, Shao C, Poe JC, Venturi GM, Shelton JM, Pop IV, Gerber DE, Girard L, Liu XY, Behrens C, Rodriguez-Canales J, Liu H, Wistuba II, Richardson JA, Minna JD, Tedder TF, Vitetta ES. Pop LM, et al. Cancer Res. 2014 Jan 1;74(1):263-71. doi: 10.1158/0008-5472.CAN-13-1436. Cancer Res. 2014. PMID: 24395821 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

355 results

Search Page